McGill.CA / Biomedical Technology & Cell Therapy Research Laboratory / Publications

Patents

  1. Prakash S and Malhotra M (2021) Methods for making peptide-tagged pegylated chitosan nanoparticles. US Patent S-20210106695-A1, Approved April 15, 2021.
  2. Satya Prakash and S. Westfall (2020) Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration. China Patent CN 111971056 A. Nov. 20, 2020. 
  3. Satya Prakash and Meenakshi Malhotra (2020) Methods for making peptide-tagged pegylated chitosan nanoparticles. US Patent 10799601B2, Approved Oct 13, 2020.
  4. Prakash, S, P Arghya, STIM Dominique (2019) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals US Patent App. 16/105,498.
  5. Prakash, S, P Arghya, STIM Dominique (2019): Therapeutic Viral Microparticles. European Divisional Patent. Patent Application No. 14783183.8 National phase of PCT/CA2014/050369 number for DIV is 6044.121967EP2. (Filled on 18 April 2019).
  6. Prakash, Satya and Paul A and Shum Tim-D (2018). Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. US Patent 10092607B2. Granted (2018).
  7. Satya Prakash and Meenakshi Malhotra (2020) Non- viral nanoparticle-based delivery system. US Patent 2018/0064826 A1, Approved March 8, 2018.
  8. Prakash, Satya and Malhotra Meenakshi (2018) Non-viral nanoparticle-based delivery system. U.S. Patent Application, US Patent App. 15/335,408, 2018.
  9. Prakash, Satya and Paul A and Shum Tim D. (2018) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. Newziland patent 714024.
  10. Prakash, Satya and Paul A and Shum Tim (2017) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. Australian Patent Application No. 2014252680 approved on 28 Sept 2017.
  11. Prakash, Satya and Westfall (2017) A novel probiotic formulation for alleviation of metabolic distress, inflammation, oxidative stress and neurodegeneration. McGill University Report of Invention (filled on 1/8/2017.
  12. Prakash, Satya and Malhotra Meenakshi (2016) Non-viral nanoparticle-based delivery system. U.S. Patent Application, Untied States Serial No. 15/335,408, Filed October 26.
  13. Prakash Satya and Paul Arghya (2016) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. E.U. Patent application No. 14783183.8, Filed 28 July 2016.
  14. Ana Luisa Martínez López, Elizabeth Carvajal Millán, Norberto Sotelo Cruz, Valérie Micard, Agustín Rascón Chu, Satya Prakash, Jaime Lizardi Mendoza, Yolanda, eticia López Franco, Rafael Carnnet Romero Alma Rosa Toledo (2015). Biodegradable covalently cross-linked matrices as a microflora-activated system for oral insulin delivery targeted to colon and process for obtaining it, Mexican Patent MX/a/2015/017857.illed 18 Dec 2015.
  15. Satya Prakash and Meenakshi Malhotra (2015) Methods for synthesizing peptide-tagged pegylated chitosan. US Patent 62/254059, Filed November 11, 2015.
  16. Satya Prakash and Arghya Paul (2015) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. China Patent application no 201480031705.8, Filed December 2nd, 2015.
  17. Satya Prakash and Arghya Paul (2015) Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. India Patent application no 10389/DELNP/2015, Filed November 9th, 2015
  18. Satya Prakash and M.L. Jones (2014) Cell and Enzyme Compositions for Modulating Bile Acids, Cholesterol and Triglycerides. US Patent Appl. No. 12/492629, CIP-approved, Sept.
  19. Satya Prakash and Meenakshi Malhotra (2013) Non-viral nanoparticle-based delivery system. US Patent Appl. No. 3916941, Filed June13, 2013
  20. Satya Prakash, Arghya Paul, Dominique Shum-Tim (2013). Therapeutic viral microparticles for promoting stent bifunctionality and wound healing in vertebrate individuals. US Provisional Patent application no. 61/811,203. Filed May 15th, 2013
  21. Satya Prakash and Meenakshi Malhotra (2013) Non-viral nanoparticle-based delivery system. Canadian Patent Appl. Application - 05001770-481CA (June 13, 2013)
  22. Satya Prakash and Meenakshi Malhotra (2012) Non-viral nanoparticle-based delivery system US 61/660,139, Filed June15, 2012
  23. Satya Prakash, Afshan Afsar Khan, Arghya Paul, Dominique Shum-Tim (2012). Novel method of using polymeric micro/nano-particles for stem cell derived growth factor cocktail delivery in wound healing and tissue regeneration applications. Filed May1, 2012. US Provisional Patent 61/646,972.
  24. Jones Mitchell and Satya Prakash (2012). Ingestible medical device. US 61/600,029. Filed 17 Feb 2012.
  25. Jones Mitchell, Christopher Martoni and Prakash, S. (2012).  Bacterial composition for prophylaxis and treatment of degenerative diseases. European Patent # 10-2011-7028620. Filed January 16, 2012.
  26. Jones Mitchell, Christopher Martoni and Prakash, S. (2012).  Bacterial composition for prophylaxis and treatment of degenerative diseases. Russian Patent # 2011148944. Filled January 21, 2012.
  27. Jones Mitchell, Christopher Martoni and Prakash, S. (2011).  Bacterial composition for prophylaxis and treatment of degenerative diseases. Korean National Phase Patent # 2011148944. Filled Dec 12, 2011.
  28. Jones M. L. and Prakash, S. (2011).  Epsilon poly-l-lysine capsules. European Patent. EP10838481.9, 11/12/2011.
  29. Jones Mitchell, and Prakash, S. (2011).  Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections. Japanese Patent # 2011-515032 Filled May 11, 2011.
  30. Jones Mitchell, Christopher Martoni and Prakash, S. (2011).  Bacterial composition for prophylaxis and treatment of degenerative diseases. Japanese Patent # F3640A1 Filled Dec 20, 2011.
  31. Prakash, S. and Malhotra, M. (2011). Non-viral nanoparticle-based delivery system. U.S. Provisional Patent.US 61/497,088 Filed on June 15, 2011.
  32. Prakash, S. and Jonathan Kanevsky and Mireco Gerodino (2010). Device and method for reducing scar formation. US Provisional Patent (2010). Filed in 8, Oct 2010. Commercialized.
  33. Jones Mitchell, Christopher Martoni and Prakash, S. (2011).  Bacterial composition for prophylaxis and treatment of degenerative diseases. Chinese Patent # 044218-8001CN01 Filled Dec 18, 2011.
  34. Jones Mitchell and Satya Prakash (2010). Bacterial composition for prophylaxis and treatment of degenerative diseases. Australian Capital Territory Patent # 2010242498 Filed April 30, 2010.
  35. Jones Mitchell and Satya Prakash (2010). Bacterial composition for prophylaxis and treatment of degenerative diseases. Tokyo. Japanese Patent 2012-5075533. Filed April 30, 2010.
  36. Jones Mitchell and Satya Prakash (2010). Bacterial composition for prophylaxis and treatment of degenerative diseases. Shanghai. Chinese Patent: CN201080029643.9 Filed April 30, 2010.
  37. Jones Mitchell, Christopher Martoni and Prakash, S. (2010).  Bacterial composition for prophylaxis and treatment of degenerative diseases. International PCT WO/2010/124387. Filed 30 April 2010.
  38. Jones Mitchell, Bhathena, J and Prakash, S. (2010). Prevention and therapy of metabolic syndrome using probiotics. U.S. 61/349,270. Filed May 28, 2010. Commercialized.
  39. Jones M. L. and Prakash, S. (2010).  Epsilon poly-l-lysine capsules. International Patent. PCT/CA2010/002057, 22/12/2010.
  40. Jones Mitchell and Prakash, S. (2010).  Bacterial composition for prophylaxis and treatment of degenerative diseases. Canadian Patent # 13935-38.
  41. Jones Mitchell and Satya Prakash (2009). Nitric oxide compositions and devices and methods for cosmesis. Washington Patent US 61/153,696 Filed on Feb 19, 2009 (Withdrawn)
  42. Jones Mitchell and Satya Prakash (2009). Nitric oxide compositions and devices and methods for cosmesis. WO/2009155690. Filed June 23, 2009. (Withdrawn)
  43. Jones Mitchell, Christopher Martoni and Prakash, S. (2009). Bacterial composition for prophylaxis and treatment of degenerative diseases. US Provisional Patent 61/174,740. Filed May 1, 2009.
  44. Jones M.L. and Prakash, S. (2009). Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections. International Patent WO/2009/ 155689.
  45. M.L. Jones and Prakash, S. (2009). Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections. US provisional. U.S. 61/075,040 filed June 24, 2008 and U.S. 61/097,978 filed September 18, 2008, and U.S. 61/166,430, April 3, 2009. Note: two improvement US provisional patents.
  46. Jones M.L. and Prakash, S. (2009). Nitric oxide compositions and devices and methods for cosmesis. International Patent. WO/2009/155689.
  47. Jones M.L. and Prakash, S. (2009). Nitric oxide compositions and devices and methods for cosmesis. U.S. Provisional Patent. Application # U.S. 61/075,040. Filed 19 Feb 2009.
  48. Jones M.L, Christopher Martoni and Prakash, S. (2009).  Epsilon poly-l-lysine capsules. U.S. Provisional Patent 61/289727.
  49. Prakash*, S. and M.L. Jones (2009) Cell and Enzyme composition for modulating bile acids, cholesterol and triglycerides. US Cont. Patent #12/492,629. Filed, June 26, 2009.
  50. Prakash, S. and M.L. Jones (2008). Nitric oxide device and methods for wound healing. U.S. Provisional Patent. # 61/097978.
  51. Prakash, S. and Saffa, S. (2008).  A novel, natural, non-Toxic, fluorescent emitting nanoparticle therapeutic molecule delivery system. US Provisional Patent (ROI 08057).
  52. Prakash, S. and Jones, M.L. (2008).  Novel wound healing formulation. U.S. Provision Patent. Application No. 61/097978.  
  53. Prakash, S. and Bhathena, J. (2008).  Novel method to produce enzyme feruloyl esterase and ferulic acid and their application thereof. International PCT patent for U.S., UK, EU, India, Canada and Japan. PCT/CAA-2008/000585. 8/2008.Commercialized.
  54. Prakash, S. and Bhathena, J. (2007). Microcapsule formulation and their use in liver failure therapy. International PCT. Filed on 13 Sept 2007).
  55. Prakash, S. and. Urbanska A. M. (2007). Microcapsule yoghurt formulation and their use in probiotic delivery. International PCT application (filed). Commercialized.
  56. Prakash, S. and J. Bhathena (2007).  Novel method to produce enzyme feruloyl esterase and ferulic acid and their application thereof US Provisional Patent. # 1464767.
  57. Prakash, S. and J. Bhathena (2006). Microcapsule formulation and their use in liver failure therapy delivery. US Provisional Patent. # 60/824/793.
  58. Prakash, S. * and Jones, M.L. (2006). Cells enzyme and its compositions for modulating bile acids, cholesterol and tri-glycerides. Hong Kong Patent HK# 06110718.4.
  59. Prakash, S. *, Chen H, Nalamasu, O, Raja  P and Ajayan P.M. (2006). Microcapsule carbon nanotube device. International Patent PCT Application No.: PCT/US2006/045412. docket No. 3965.1000002, Filed on Nov 21, 2006.
  60. Prakash, S. and Aleksandra Malgorzata Urbanska (2006). Microcapsule yoghurt formulation and their use in probiotic delivery. US Provisional Patent. 14647-59. 7/2006 Commercialized.
  61. Prakash, S. *, Chen H, Nalamasu, O, Raja  P and Ajayan P.M. (2005). Microcapsule carbon nanotube device. U.S. Provisional Application No. 60/739,593.
  62. Prakash, S. * and M.L. Jones (2004). Bacterial cells for bile acid intake and/or lowering cholesterol: immobilized, microencapsulated. European Patent # 04715862.
  63. Prakash, S. * and M.L. Jones. (2004). Bacterial cells for bile acid intake and/or lowering cholesterol: immobilized, Microencapsulated. US Patent # 7,939,061 Commercialized.
  64. Prakash, S. * and M.L. Jones (2004). Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides. Canada Patent #2,517,245.
  65. Prakash, S. * and M.L. Jones (2004) Cell and Enzyme Compositions for Modulating Bile Acids, Cholesterol and Triglycerides. International PCT WO/2004/076657.
  66. Prakash, S. * and M.L. Jones (2003). Microencapsulated and/or Immobilized Enzyme and/or Bacteria for Lowering Bile Acid and/or Cholesterol. US Provisional Patent (US 60/450,334). Filed Feb 28, 2003. Commercialized.
  67. Prakash, S. and Chang, T.M.S. (2002). Microencapsulated genetically engineered microorganisms for clinical application. European Union (EU) Patent.
  68. Prakash, S. and Chang, T.M.S. (2002). Micro-organismes microencapsules issus du genie genetique pour applications cliniques. CA Patent # 2243352.
  69. Chang, T.M.S. and Prakash, S. (2001). Microencapsulated genetically engineered microorganisms for clinical application. U.S. Patent: No.621785.
  70. Chang, T.M.S. and Prakash, S. (2001). Artificial cell containing genetically engineered microorganisms for clinical application Japan Patent No. 9526371, 1770-138JP.
  71. Prakash, S. and Chang, T.M.S. (2001). Artificial cells containing genetically engineered E. coli DH5 cells for lowering of plasma electrolyte. International Patent (PTC) for EU, UK, USA, Canada, Japan, India, & China :S. No. 9899073.
  72. Prakash, S. and Chang, T.M.S. (1999). Artificial Cells containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma K, Na, Mg, Cl, Creatinine, Cholesterol, Bilirubin, & Uric Acid for various clinical applications. U.S. Priority Patent S.No.60/ 131,46816.
  73. Chang, T.M.S. and Prakash, S. (1997). Microencapsulated genetically engineered microorganisms for lowering plasma urea and ammonia for clinical applications. International PATENT (PTC) for EU, UK, USA, Canada, and Japan (PCT/CA97/00040).
  74. Prakash, S. and Chang, T.M.S (1996). Microencapsulated genetically engineered E. coli DH5 cells for clinical applications. British Priority Patent No.960133-9.
Back to top